PATIENT_ID
SEX
AGE
SMOKER
LINES_OF_TX
IRB
TREATMENT_TYPE
PFS_MONTHS
DURABLE_CLINICAL_BENEFIT
study_name_x
HISTOLOGY
SMOKING_HISTORY
SMOKING_PACK_YEARS
PDL1_EXPRESSION
PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY
AGENT
MOLECULAR_SMOKING_SIGNATURE
NONSYNONYMOUS_MUTATION_BURDEN
NEOANTIGEN_BURDEN
TOTAL_EXONIC_MUTATION_BURDEN
OTHER_PATIENT_ID
AGE_CURRENT
RACE
RELIGION
OS_STATUS
OS_MONTHS
PED_IND
SEX_DMT
CRDB_SURVIVAL_STATUS
SMOKER_PACK_YEARS
DOSAGE
OVERALL_RESPONSE
AGE_AT_SURGERY
AGE_YRS
SMOKING_STATUS
PDL1_EXP
BEST_OVERALL_RESPONSE
PREDICTED_NEOANTIGEN_BURDEN
SAMPLE_ID
GENE_PANEL
ONCOTREE_CODE
MUTATION_RATE
FGA
PDL1_SCORE
CANCER_TYPE
CANCER_TYPE_DETAILED
SOMATIC_STATUS
TMB_NONSYNONYMOUS
study_name_y
NOTE
SAMPLE_TYPE
METASTATIC_SITE
PRIMARY_SITE
ETHNICITY
SO_COMMENTS
SAMPLE_COVERAGE
TUMOR_PURITY
MSI_SCORE
MSI_TYPE
INSTITUTE
AGE_AT_SEQ_REPORTED_YEARS
ARCHER
PATH_SLIDE_EXISTS
MSK_SLIDE_ID
TISSUE_SOURCE_SITE
PATHOLOGIC_STAGE
PREDOMINANT_HISTOLOGIC_SUBTYPE
FGA_FACETS
TMB
